| 书目名称 | New Approaches in Cancer Pharmacology: Drug Design and Development | | 副标题 | Vol. II | | 编辑 | Paul Workman (Chairman),Maurizio D’lncalci (Co-Cha | | 视频video | | | 丛书名称 | ESO Monographs | | 图书封面 |  | | 描述 | The European School of Oncology came into existence to respond to a need for information, education and training in the field of the diagnosis and treatment of cancer. There are two main reasons why such an initiative was considered necessary. Firstly, the teaching of oncology requires a rigorously multidisciplinary approach which is difficult for the Universities to put into practice since their system is mainly disciplinary orientated. Secondly, the rate of technological development that impinges on the diagnosis and treatment of cancer has been so rapid that it is not an easy task for medical faculties to adapt their curricula flexibly. With its residential courses for organ pathologies and the seminars on new techniques (laser, monoclonal antibodies, imaging techniques etc.) or on the principal therapeutic controversies (conservative or mutilating surgery, primary or adjuvant chemotherapy, radiotherapy alone or integrated), it is the ambition of the European School of Oncology to fill a cultural and scientific gap and, thereby, create a bridge between the University and Industry and between these two and daily medical practice. One of the more recent initiatives of ESO has been | | 出版日期 | Conference proceedings 1994 | | 关键词 | Cancer Pharmacology; Krebs; Pharmakologie; Pharmastruktur; apoptosis; biology; cancer; cancer therapy; clini | | 版次 | 1 | | doi | https://doi.org/10.1007/978-3-642-79088-1 | | isbn_softcover | 978-3-642-79090-4 | | isbn_ebook | 978-3-642-79088-1 | | copyright | Springer-Verlag Berlin Heidelberg 1994 |
The information of publication is updating
|
|
发表于 2025-3-21 18:36:44
